about
Crizotinib-Induced Abnormal Signal Processing in the RetinaMulticenter Phase II Study of Nedaplatin and Irinotecan for Patients with Squamous Cell Carcinoma of the Lung: Thoracic Oncology Research Group 0910.Chronic obstructive pulmonary disease as a risk factor for lung cancerDrug resistance originating from a TGF-β/FGF-2-driven epithelial-to-mesenchymal transition and its reversion in human lung adenocarcinoma cell lines harboring an EGFR mutation.Safety of a short hydration method for cisplatin administration in comparison with a conventional method-a retrospective study.Current status of medical oncology in Japan--reality gleaned from a questionnaire sent to designated cancer care hospitals.MYC/BCL2 Double-hit Lymphoma in a Patient with Rheumatoid Arthritis Associated with Methotrexate Treatment.Choroidal metastasis of non-small cell lung cancer that responded to gefitinib.Stereotactic radiosurgery for patients with brain metastases.Ablation of miR-146b in mice causes hematopoietic malignancyMalignant peritoneal mesothelioma: quantitative analysis of asbestos burdenIncidence, risk factors and treatment outcomes of extravasation of cytotoxic agents in an outpatient chemotherapy clinicAlveolar hemorrhage associated with pemetrexed administrationProphylactic dexamethasone for radiation-induced bone-pain flareEosinophilic Fasciitis Illustrated by [(18)F] FDG-PET/CT[Monitoring the side effects of cancer chemotherapy]
P50
Q28547218-9430685D-3CB6-4501-AB8F-31DB5CFD38E4Q33428188-1868EE71-A9BB-4A2B-9B3B-0A8B92D05F2CQ34031235-F37AED60-2964-45F8-A386-439586F9FDC7Q36734197-1F1F8AFF-0678-4929-9869-04021FD0E436Q36949303-91AE876C-442E-4C05-BAEA-A3CBA63F792EQ39193533-920124B0-2F4C-4F8C-8D41-519E1A1AA15FQ40092749-8FF19FE3-76A5-4CBA-85F3-CC362407C203Q42006601-6DB7A465-EC6C-4CA7-BE56-960E9A1845C6Q48759705-ECEC9B80-8D2F-4720-8D42-86689DE7C101Q59790131-BABA0FCA-EE99-4406-87F6-17B0F378D87AQ84832144-C80C9AF7-1F21-409C-8A21-594C823B528AQ86887320-95BCDD61-D5BA-45AD-9833-3CFAAB1A54A3Q87037605-C2052385-2D7A-434D-BC16-012C70474933Q87273851-63CF133D-EC4A-4B29-8FF3-74E9E95734CCQ88123709-C9F014D4-C971-47B1-9CFE-50C479E7B34EQ95621598-6FC8D321-9F44-4FBC-8A49-890F7118F016
P50
description
researcher ORCID ID = 0000-0003-3029-5287
@en
wetenschapper
@nl
name
Ryota Kurimoto
@ast
Ryota Kurimoto
@en
Ryota Kurimoto
@es
Ryota Kurimoto
@nl
type
label
Ryota Kurimoto
@ast
Ryota Kurimoto
@en
Ryota Kurimoto
@es
Ryota Kurimoto
@nl
prefLabel
Ryota Kurimoto
@ast
Ryota Kurimoto
@en
Ryota Kurimoto
@es
Ryota Kurimoto
@nl
P106
P31
P496
0000-0003-3029-5287